PROVECTUS BIOPHARMACEUTICALS's ticker is PVCT and the CUSIP is 74373P108. A total of 7 filers reported holding PROVECTUS BIOPHARMACEUTICALS in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Cormorant Asset Management, LP | 2,226,961 | $221,000 | 0.02% |
HOME FEDERAL BANK OF TENNESSEE | 100,000 | $10,000 | 0.01% |
SABBY MANAGEMENT, LLC | 1,077,555 | $107,000 | 0.00% |
Cutter & CO Brokerage, Inc. | 79,500 | $8,000 | 0.00% |
Virtu KCG Holdings LLC | 364,520 | $36,000 | 0.00% |
Tower Research Capital LLC (TRC) | 81,647 | $8,000 | 0.00% |
WADE G W & INC | 80,000 | $8,000 | 0.00% |
PRINCETON CAPITAL MANAGEMENT LLC | 10,000 | $1,000 | 0.00% |
BANK OF AMERICA CORP /DE/ | 29,358 | $3,000 | 0.00% |
WELLS FARGO & COMPANY/MN | 4,500 | $0 | 0.00% |